These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26803050)

  • 1. Therapeutic drug monitoring in neonates.
    Pauwels S; Allegaert K
    Arch Dis Child; 2016 Apr; 101(4):377-81. PubMed ID: 26803050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
    Allegaert K; Flint R; Smits A
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.
    Samardzic J; Allegaert K; Wilbaux M; Pfister M; van den Anker JN
    Expert Opin Drug Metab Toxicol; 2016; 12(4):367-75. PubMed ID: 26817821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
    Prokopczyk J; Piekarczyk A; Kaminska E
    Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation.
    Völler S; Flint RB; Stolk LM; Degraeuwe PLJ; Simons SHP; Pokorna P; Burger DM; de Groot R; Tibboel D; Knibbe CAJ;
    Eur J Pharm Sci; 2017 Nov; 109S():S90-S97. PubMed ID: 28506869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
    Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to use vancomycin optimally in neonates: remaining questions.
    Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
    Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
    Kadambari S; Heath PT; Sharland M; Lewis S; Nichols A; Turner MA
    J Antimicrob Chemother; 2011 Nov; 66(11):2647-50. PubMed ID: 21862473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring and pharmacokinetic dose prediction methods.
    Oellerich M
    Wien Klin Wochenschr Suppl; 1992; 191():12-5. PubMed ID: 1509745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.
    Tang BH; Zhang JY; Allegaert K; Hao GX; Yao BF; Leroux S; Thomson AH; Yu Z; Gao F; Zheng Y; Zhou Y; Capparelli EV; Biran V; Simon N; Meibohm B; Lo YL; Marques R; Peris JE; Lutsar I; Saito J; Jacqz-Aigrain E; van den Anker J; Wu YE; Zhao W
    Clin Pharmacokinet; 2023 Aug; 62(8):1105-1116. PubMed ID: 37300630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
    Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
    Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.